A recent branch of cardiovascular medicine called molecular cardiology seeks to use molecular biology methods for the mechanistic analysis, detection, diagnosis, and therapy of cardiovascular illness. Its main objective is to identify novel pathways that affect cardiac hypertrophy, ageing, and metabolic disorders, paying close attention to how each discovery might be translated into fresh bedside methods and tactics.
Cellular cardiology: Heart failure is among the leading causes of death in the modern world. The study of the heart or circulatory system at the cellular level is known as cellular cardiology. In this molecular cardiology, the researchers found that the cells in various heart regions differed significantly from one another and that each part of the organ included a distinct group of cells, revealing various developmental origins and possibly varying responses to therapies. The molecular and cellular biology methods that are most frequently employed include:
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China